Cleared Traditional

K883313 - PMT VASCULAR CATHETER MODEL NUMBER 3621-1

K883313 is the FDA 510(k) clearance for PMT VASCULAR CATHETER MODEL NUMBER 3621-1 by Pmt Corp.. It is a Class 2 General Hospital device (product code LJS) cleared through the Traditional 510(k) pathway after a 60-day FDA review.

K883313 · Pmt Corp. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1988
Decision
60d
Days
Class 2
Risk

K883313 is an FDA 510(k) clearance for the PMT VASCULAR CATHETER MODEL NUMBER 3621-1. Classified as Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days (product code LJS), Class II - Special Controls.

Submitted by Pmt Corp. (Chanhassen, US). The FDA issued a Cleared decision on October 4, 1988 after a review of 60 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5970 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Pmt Corp. devices

Submission Details

510(k) Number K883313 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 05, 1988
Decision Date October 04, 1988
Days to Decision 60 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
69d faster than avg
Panel avg: 129d · This submission: 60d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LJS Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5970
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - LJS Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days

All 161
Devices cleared under the same product code (LJS) and FDA review panel - the closest regulatory comparables to K883313.
EPICUTANEO-CAVA CATHETER CODE 2184
K897168 · Vygon Corp. · Apr 1990
PERCUTANEOUS INTRAVENOUS CATHETERS
K895712 · Pharmacia Deltec, Inc. · Dec 1989
DESERET(R) INTRODUCER SET WITH VITACUFF(R) DEVICE
K893126 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Aug 1989
MULTILUMEN CENTRAL VENOUS CATH. W/VITACUFF DEVICE
K882448 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Aug 1988
VAPOR-SEAL(TM) PERCUTANEOUS CATHETERS
K864086 · Pharmacia, Inc. · Apr 1987
GRECO-HARVEY SURFACT BOND CATH HYPERALIMENTATION
K851243 · Cook, Inc. · Mar 1986